Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Risk of oral contraceptives and recency of market introduction — Jan P. Vandenbroucke (1997) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Risk of oral contraceptives and recency of market introduction
Shared by
Frits R. Rosendaal
Risk of oral contraceptives and recency of market introduction
Letter
1997
English
Authors
+1 more
JV
Jan P. Vandenbroucke
KB
Kitty W.M. Bloemenkamp
FH
Frans M. Helmerhorst
Abstract
1 min read
No abstract is provided for this article.
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Letter
1999
Venous thromboembolism and oral contraceptives
Kitty W.M. Bloemenkamp
,
Frits R. Rosendaal
,
Frans M. Helmerhorst
,
Jan P. Vandenbroucke
The Lancet
Article
1997
Oral contraceptives and venous thromboembolism
Jan P. Vandenbroucke
,
Frits R. Rosendaal
The Lancet
Article
1997
Oral contraceptives and venous thromboembolism (reply)
Frits R. Rosendaal
Article
2014
Combined oral contraceptives: venous thrombosis
Marcos Bastos Pereira
,
Bernardine H. Stegeman
,
Frits R. Rosendaal
,
Astrid van Hylckama Vlieg
,
Frans M. Helmerhorst
,
Theo Stijnen
,
Olaf M. Dekkers
Cochrane library
Letter
1997
Third-generation oral contraceptives and venous thrombosis
Jan P. Vandenbroucke
,
Frans M. Helmerhorst
,
Kitty W.M. Bloemenkamp
,
Frits R. Rosendaal
The Lancet
.jpg){kind=small}
Discussion(0)
No comments yet. Be the first to comment.